It was an unexpected finding that no interaction was observed between IGF-1 and serum 25(OH)D in this study, as we anticipated an association with increased risk of prostate cancer, given the role of IGF-1 in prostate carcinogenesis [45,46]. This evidence concerns the gene IGF1 and prostate cancer.